Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5Sarcoma 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Leukemia, Myeloid, Acute 125Myelodysplastic Syndromes 118Precursor Cell Lymphoblastic Leukemia-Lymphoma 107Leukemia 86Leukemia, Lymphocytic, Chronic, B-Cell 78Hodgkin Disease 78Lymphoma, Non-Hodgkin 73Lymphoma 73Multiple Myeloma 66Myeloproliferative Disorders 57Graft vs Host Disease 52Lymphoma, Follicular 51Leukemia, Myeloid, Accelerated Phase 50Lymphoma, Mantle-Cell 49Lymphoma, Large B-Cell, Diffuse 49Leukemia, Myelomonocytic, Chronic 48Congenital Abnormalities 48Leukemia, Myelogenous, Chronic, BCR-ABL Positive 47Hematologic Neoplasms 45Lymphoma, B-Cell, Marginal Zone 44Leukemia, Myeloid, Chronic-Phase 44Burkitt Lymphoma 41Primary Myelofibrosis 40Blast Crisis 39Neoplasms, Plasma Cell 36Lymphoma, Large-Cell, Immunoblastic 34Waldenstrom Macroglobulinemia 26Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Myelodysplastic-Myeloproliferative Diseases 24Anemia, Refractory, with Excess of Blasts 24

Interventions

Cyclophosphamide 8Flow Cytometry 6Methylprednisolone 5Melphalan 5Therapeutics 4Psychiatric Rehabilitation 4Busulfan 4Antilymphocyte Serum 4Radiotherapy 3Polymerase Chain Reaction 3Immunologic Techniques 3Filgrastim 3Caspofungin 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3venetoclax 2thymoglobulin 2liposomal amphotericin B 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Voriconazole 2Thiotepa 2Thalidomide 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Nivolumab 2Itraconazole 2Ipilimumab 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Tacrolimus × Other hematologic neoplasm × Clear all
NCT00109993 2010-06-11

Campath-1H + FK506 and Methylprednisolone for GVHD

Case Comprehensive Cancer Center

Phase 2 Completed
34 enrolled
BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Testicular Germ Cell Tumor, Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neuroblastoma, Ovarian Neoplasms, Sezary Syndrome, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡